Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype s...
Leadership
Brian Lian Ph.D.
President, CEO & Director
Gregory S. Zante CPA
Chief Financial Officer
Marianne Mancini
Chief Operating Officer
Michael Morneau
Vice President of Finance & Administration
Katherine Mercier
Vice President of Quality and Compliance
Kenneth J. Herman M.B.A.
Senior Vice President of Commercial, Marketing & Sales
